nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP2C19—epilepsy syndrome	0.108	0.44	CbGaD
Cyclophosphamide—CYP2D6—epilepsy syndrome	0.08	0.326	CbGaD
Cyclophosphamide—ABCB1—epilepsy syndrome	0.0571	0.233	CbGaD
Cyclophosphamide—CYP2C18—Clobazam—epilepsy syndrome	0.0285	0.0509	CbGbCtD
Cyclophosphamide—CYP2C18—Phenytoin—epilepsy syndrome	0.0212	0.0378	CbGbCtD
Cyclophosphamide—CYP2C18—Propofol—epilepsy syndrome	0.0198	0.0353	CbGbCtD
Cyclophosphamide—CYP2C18—Phenobarbital—epilepsy syndrome	0.0189	0.0337	CbGbCtD
Cyclophosphamide—CYP2C18—Diazepam—epilepsy syndrome	0.0179	0.032	CbGbCtD
Cyclophosphamide—CYP2C18—Valproic Acid—epilepsy syndrome	0.0141	0.0252	CbGbCtD
Cyclophosphamide—CYP2A6—Amobarbital—epilepsy syndrome	0.0129	0.023	CbGbCtD
Cyclophosphamide—CYP2B6—Fosphenytoin—epilepsy syndrome	0.0104	0.0186	CbGbCtD
Cyclophosphamide—CYP2A6—Propofol—epilepsy syndrome	0.0096	0.0171	CbGbCtD
Cyclophosphamide—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00937	0.0167	CbGbCtD
Cyclophosphamide—CYP2A6—Phenobarbital—epilepsy syndrome	0.00918	0.0164	CbGbCtD
Cyclophosphamide—CYP2B6—Clobazam—epilepsy syndrome	0.00902	0.0161	CbGbCtD
Cyclophosphamide—CYP2C8—Trimethadione—epilepsy syndrome	0.00838	0.015	CbGbCtD
Cyclophosphamide—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00788	0.0141	CbGbCtD
Cyclophosphamide—CYP3A7—Carbamazepine—epilepsy syndrome	0.00785	0.014	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00785	0.014	CbGbCtD
Cyclophosphamide—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00756	0.0135	CbGbCtD
Cyclophosphamide—CYP2B6—Carbamazepine—epilepsy syndrome	0.00747	0.0133	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00704	0.0126	CbGbCtD
Cyclophosphamide—CYP3A7—Phenytoin—epilepsy syndrome	0.00704	0.0126	CbGbCtD
Cyclophosphamide—CYP2C19—Trimethadione—epilepsy syndrome	0.00703	0.0126	CbGbCtD
Cyclophosphamide—CYP2C19—Felbamate—epilepsy syndrome	0.00703	0.0126	CbGbCtD
Cyclophosphamide—CYP2B6—Primidone—epilepsy syndrome	0.00698	0.0125	CbGbCtD
Cyclophosphamide—CYP2A6—Valproic Acid—epilepsy syndrome	0.00686	0.0122	CbGbCtD
Cyclophosphamide—CYP2B6—Phenytoin—epilepsy syndrome	0.0067	0.012	CbGbCtD
Cyclophosphamide—ABCB1—Levetiracetam—epilepsy syndrome	0.00667	0.0119	CbGbCtD
Cyclophosphamide—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00661	0.0118	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00627	0.0112	CbGbCtD
Cyclophosphamide—CYP3A7—Phenobarbital—epilepsy syndrome	0.00627	0.0112	CbGbCtD
Cyclophosphamide—CYP2B6—Propofol—epilepsy syndrome	0.00625	0.0112	CbGbCtD
Cyclophosphamide—CYP3A7—Midazolam—epilepsy syndrome	0.00619	0.011	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00619	0.011	CbGbCtD
Cyclophosphamide—CYP2B6—Phenobarbital—epilepsy syndrome	0.00597	0.0107	CbGbCtD
Cyclophosphamide—CYP3A7—Diazepam—epilepsy syndrome	0.00595	0.0106	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00595	0.0106	CbGbCtD
Cyclophosphamide—CYP2B6—Midazolam—epilepsy syndrome	0.00589	0.0105	CbGbCtD
Cyclophosphamide—CYP3A5—Carbamazepine—epilepsy syndrome	0.00589	0.0105	CbGbCtD
Cyclophosphamide—CYP2C9—Trimethadione—epilepsy syndrome	0.00584	0.0104	CbGbCtD
Cyclophosphamide—CYP2C19—Clobazam—epilepsy syndrome	0.00573	0.0102	CbGbCtD
Cyclophosphamide—CYP2B6—Diazepam—epilepsy syndrome	0.00566	0.0101	CbGbCtD
Cyclophosphamide—CYP2C8—Carbamazepine—epilepsy syndrome	0.00566	0.0101	CbGbCtD
Cyclophosphamide—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00549	0.00981	CbGbCtD
Cyclophosphamide—CYP2C8—Primidone—epilepsy syndrome	0.00528	0.00944	CbGbCtD
Cyclophosphamide—CYP3A5—Phenytoin—epilepsy syndrome	0.00528	0.00943	CbGbCtD
Cyclophosphamide—CYP2C8—Phenytoin—epilepsy syndrome	0.00508	0.00907	CbGbCtD
Cyclophosphamide—CYP2C19—Carbamazepine—epilepsy syndrome	0.00475	0.00848	CbGbCtD
Cyclophosphamide—CYP2C8—Propofol—epilepsy syndrome	0.00473	0.00846	CbGbCtD
Cyclophosphamide—CYP3A5—Phenobarbital—epilepsy syndrome	0.00471	0.0084	CbGbCtD
Cyclophosphamide—CYP3A5—Midazolam—epilepsy syndrome	0.00464	0.00829	CbGbCtD
Cyclophosphamide—ABCB1—Clobazam—epilepsy syndrome	0.00462	0.00826	CbGbCtD
Cyclophosphamide—CYP2C8—Phenobarbital—epilepsy syndrome	0.00452	0.00808	CbGbCtD
Cyclophosphamide—CYP2B6—Valproic Acid—epilepsy syndrome	0.00446	0.00797	CbGbCtD
Cyclophosphamide—CYP3A5—Diazepam—epilepsy syndrome	0.00446	0.00797	CbGbCtD
Cyclophosphamide—ABCB1—Lamotrigine—epilepsy syndrome	0.00445	0.00795	CbGbCtD
Cyclophosphamide—CYP2C19—Primidone—epilepsy syndrome	0.00443	0.00792	CbGbCtD
Cyclophosphamide—CYP2C8—Diazepam—epilepsy syndrome	0.00429	0.00766	CbGbCtD
Cyclophosphamide—CYP2C19—Phenytoin—epilepsy syndrome	0.00426	0.00761	CbGbCtD
Cyclophosphamide—CYP2C19—Propofol—epilepsy syndrome	0.00397	0.00709	CbGbCtD
Cyclophosphamide—CYP2C9—Carbamazepine—epilepsy syndrome	0.00395	0.00705	CbGbCtD
Cyclophosphamide—ABCB1—Carbamazepine—epilepsy syndrome	0.00383	0.00684	CbGbCtD
Cyclophosphamide—CYP2C19—Phenobarbital—epilepsy syndrome	0.0038	0.00678	CbGbCtD
Cyclophosphamide—CYP2C9—Primidone—epilepsy syndrome	0.00369	0.00658	CbGbCtD
Cyclophosphamide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00366	0.00653	CbGbCtD
Cyclophosphamide—CYP2C19—Diazepam—epilepsy syndrome	0.0036	0.00643	CbGbCtD
Cyclophosphamide—CYP2C9—Phenytoin—epilepsy syndrome	0.00354	0.00632	CbGbCtD
Cyclophosphamide—CYP3A5—Valproic Acid—epilepsy syndrome	0.00352	0.00628	CbGbCtD
Cyclophosphamide—CYP2C19—Zonisamide—epilepsy syndrome	0.00351	0.00627	CbGbCtD
Cyclophosphamide—ABCB1—Phenytoin—epilepsy syndrome	0.00344	0.00614	CbGbCtD
Cyclophosphamide—CYP3A4—Felbamate—epilepsy syndrome	0.0034	0.00607	CbGbCtD
Cyclophosphamide—CYP3A4—Trimethadione—epilepsy syndrome	0.0034	0.00607	CbGbCtD
Cyclophosphamide—CYP2C8—Valproic Acid—epilepsy syndrome	0.00338	0.00604	CbGbCtD
Cyclophosphamide—CYP2C9—Propofol—epilepsy syndrome	0.0033	0.0059	CbGbCtD
Cyclophosphamide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00319	0.00571	CbGbCtD
Cyclophosphamide—CYP2C9—Phenobarbital—epilepsy syndrome	0.00316	0.00564	CbGbCtD
Cyclophosphamide—ABCB1—Phenobarbital—epilepsy syndrome	0.00306	0.00547	CbGbCtD
Cyclophosphamide—ABCB1—Midazolam—epilepsy syndrome	0.00302	0.00539	CbGbCtD
Cyclophosphamide—CYP2D6—Propofol—epilepsy syndrome	0.00302	0.00539	CbGbCtD
Cyclophosphamide—CYP2C9—Diazepam—epilepsy syndrome	0.00299	0.00534	CbGbCtD
Cyclophosphamide—ABCB1—Diazepam—epilepsy syndrome	0.0029	0.00519	CbGbCtD
Cyclophosphamide—CYP3A4—Clonazepam—epilepsy syndrome	0.00289	0.00516	CbGbCtD
Cyclophosphamide—CYP2C19—Valproic Acid—epilepsy syndrome	0.00284	0.00507	CbGbCtD
Cyclophosphamide—CYP3A4—Clobazam—epilepsy syndrome	0.00277	0.00495	CbGbCtD
Cyclophosphamide—CYP2C19—Topiramate—epilepsy syndrome	0.00256	0.00457	CbGbCtD
Cyclophosphamide—CYP2C9—Valproic Acid—epilepsy syndrome	0.00236	0.00421	CbGbCtD
Cyclophosphamide—CYP3A4—Rufinamide—epilepsy syndrome	0.00236	0.00421	CbGbCtD
Cyclophosphamide—CYP3A4—Carbamazepine—epilepsy syndrome	0.0023	0.0041	CbGbCtD
Cyclophosphamide—CYP3A4—Primidone—epilepsy syndrome	0.00214	0.00383	CbGbCtD
Cyclophosphamide—CYP3A4—Phenytoin—epilepsy syndrome	0.00206	0.00368	CbGbCtD
Cyclophosphamide—CYP3A4—Propofol—epilepsy syndrome	0.00192	0.00343	CbGbCtD
Cyclophosphamide—CYP3A4—Phenobarbital—epilepsy syndrome	0.00183	0.00328	CbGbCtD
Cyclophosphamide—CYP3A4—Acetazolamide—epilepsy syndrome	0.00183	0.00328	CbGbCtD
Cyclophosphamide—CYP3A4—Midazolam—epilepsy syndrome	0.00181	0.00323	CbGbCtD
Cyclophosphamide—CYP3A4—Diazepam—epilepsy syndrome	0.00174	0.00311	CbGbCtD
Cyclophosphamide—CYP3A4—Zonisamide—epilepsy syndrome	0.0017	0.00303	CbGbCtD
Cyclophosphamide—CYP3A4—Valproic Acid—epilepsy syndrome	0.00137	0.00245	CbGbCtD
Cyclophosphamide—CYP3A4—Topiramate—epilepsy syndrome	0.00124	0.00221	CbGbCtD
Cyclophosphamide—Ifosfamide—CYP2C19—epilepsy syndrome	0.000701	1	CrCbGaD
Cyclophosphamide—Vomiting—Fosphenytoin—epilepsy syndrome	3.41e-05	0.000216	CcSEcCtD
Cyclophosphamide—Diarrhoea—Felbamate—epilepsy syndrome	3.41e-05	0.000216	CcSEcCtD
Cyclophosphamide—Body temperature increased—Lamotrigine—epilepsy syndrome	3.4e-05	0.000215	CcSEcCtD
Cyclophosphamide—Dysgeusia—Gabapentin—epilepsy syndrome	3.4e-05	0.000215	CcSEcCtD
Cyclophosphamide—Dizziness—Diazepam—epilepsy syndrome	3.4e-05	0.000215	CcSEcCtD
Cyclophosphamide—Infection—Valproic Acid—epilepsy syndrome	3.4e-05	0.000215	CcSEcCtD
Cyclophosphamide—Leukopenia—Pregabalin—epilepsy syndrome	3.39e-05	0.000215	CcSEcCtD
Cyclophosphamide—Rash—Fosphenytoin—epilepsy syndrome	3.38e-05	0.000214	CcSEcCtD
Cyclophosphamide—Dermatitis—Fosphenytoin—epilepsy syndrome	3.38e-05	0.000214	CcSEcCtD
Cyclophosphamide—Haemoglobin—Topiramate—epilepsy syndrome	3.38e-05	0.000214	CcSEcCtD
Cyclophosphamide—Asthenia—Clonazepam—epilepsy syndrome	3.37e-05	0.000213	CcSEcCtD
Cyclophosphamide—Rhinitis—Topiramate—epilepsy syndrome	3.37e-05	0.000213	CcSEcCtD
Cyclophosphamide—Headache—Fosphenytoin—epilepsy syndrome	3.36e-05	0.000213	CcSEcCtD
Cyclophosphamide—Haemorrhage—Topiramate—epilepsy syndrome	3.36e-05	0.000213	CcSEcCtD
Cyclophosphamide—Hepatitis—Topiramate—epilepsy syndrome	3.36e-05	0.000213	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	3.35e-05	0.000212	CcSEcCtD
Cyclophosphamide—Palpitations—Pregabalin—epilepsy syndrome	3.35e-05	0.000212	CcSEcCtD
Cyclophosphamide—Asthenia—Phenytoin—epilepsy syndrome	3.35e-05	0.000212	CcSEcCtD
Cyclophosphamide—Nausea—Midazolam—epilepsy syndrome	3.34e-05	0.000212	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Topiramate—epilepsy syndrome	3.34e-05	0.000212	CcSEcCtD
Cyclophosphamide—Muscle spasms—Gabapentin—epilepsy syndrome	3.34e-05	0.000211	CcSEcCtD
Cyclophosphamide—Tachycardia—Valproic Acid—epilepsy syndrome	3.34e-05	0.000211	CcSEcCtD
Cyclophosphamide—Diarrhoea—Zonisamide—epilepsy syndrome	3.34e-05	0.000211	CcSEcCtD
Cyclophosphamide—Asthenia—Oxcarbazepine—epilepsy syndrome	3.33e-05	0.000211	CcSEcCtD
Cyclophosphamide—Pruritus—Clonazepam—epilepsy syndrome	3.32e-05	0.00021	CcSEcCtD
Cyclophosphamide—Vomiting—Vigabatrin—epilepsy syndrome	3.32e-05	0.00021	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Valproic Acid—epilepsy syndrome	3.31e-05	0.000209	CcSEcCtD
Cyclophosphamide—Cough—Pregabalin—epilepsy syndrome	3.31e-05	0.000209	CcSEcCtD
Cyclophosphamide—Pruritus—Phenytoin—epilepsy syndrome	3.3e-05	0.000209	CcSEcCtD
Cyclophosphamide—Nausea—Levetiracetam—epilepsy syndrome	3.3e-05	0.000209	CcSEcCtD
Cyclophosphamide—Rash—Vigabatrin—epilepsy syndrome	3.3e-05	0.000209	CcSEcCtD
Cyclophosphamide—Dizziness—Felbamate—epilepsy syndrome	3.29e-05	0.000208	CcSEcCtD
Cyclophosphamide—Dermatitis—Vigabatrin—epilepsy syndrome	3.29e-05	0.000208	CcSEcCtD
Cyclophosphamide—Pruritus—Oxcarbazepine—epilepsy syndrome	3.28e-05	0.000208	CcSEcCtD
Cyclophosphamide—Convulsion—Pregabalin—epilepsy syndrome	3.28e-05	0.000208	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.28e-05	0.000208	CcSEcCtD
Cyclophosphamide—Vision blurred—Gabapentin—epilepsy syndrome	3.28e-05	0.000207	CcSEcCtD
Cyclophosphamide—Headache—Vigabatrin—epilepsy syndrome	3.27e-05	0.000207	CcSEcCtD
Cyclophosphamide—Hypertension—Pregabalin—epilepsy syndrome	3.27e-05	0.000207	CcSEcCtD
Cyclophosphamide—Vomiting—Diazepam—epilepsy syndrome	3.27e-05	0.000207	CcSEcCtD
Cyclophosphamide—Anorexia—Valproic Acid—epilepsy syndrome	3.26e-05	0.000206	CcSEcCtD
Cyclophosphamide—Tremor—Gabapentin—epilepsy syndrome	3.26e-05	0.000206	CcSEcCtD
Cyclophosphamide—Rash—Diazepam—epilepsy syndrome	3.24e-05	0.000205	CcSEcCtD
Cyclophosphamide—Dermatitis—Diazepam—epilepsy syndrome	3.24e-05	0.000205	CcSEcCtD
Cyclophosphamide—Visual impairment—Topiramate—epilepsy syndrome	3.24e-05	0.000205	CcSEcCtD
Cyclophosphamide—Arthralgia—Pregabalin—epilepsy syndrome	3.23e-05	0.000204	CcSEcCtD
Cyclophosphamide—Chest pain—Pregabalin—epilepsy syndrome	3.23e-05	0.000204	CcSEcCtD
Cyclophosphamide—Myalgia—Pregabalin—epilepsy syndrome	3.23e-05	0.000204	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.22e-05	0.000204	CcSEcCtD
Cyclophosphamide—Dizziness—Zonisamide—epilepsy syndrome	3.22e-05	0.000204	CcSEcCtD
Cyclophosphamide—Headache—Diazepam—epilepsy syndrome	3.22e-05	0.000204	CcSEcCtD
Cyclophosphamide—Diarrhoea—Clonazepam—epilepsy syndrome	3.21e-05	0.000203	CcSEcCtD
Cyclophosphamide—Anaemia—Gabapentin—epilepsy syndrome	3.21e-05	0.000203	CcSEcCtD
Cyclophosphamide—Hypotension—Valproic Acid—epilepsy syndrome	3.2e-05	0.000202	CcSEcCtD
Cyclophosphamide—Asthenia—Carbamazepine—epilepsy syndrome	3.2e-05	0.000202	CcSEcCtD
Cyclophosphamide—Agitation—Gabapentin—epilepsy syndrome	3.19e-05	0.000202	CcSEcCtD
Cyclophosphamide—Diarrhoea—Phenytoin—epilepsy syndrome	3.19e-05	0.000202	CcSEcCtD
Cyclophosphamide—Discomfort—Pregabalin—epilepsy syndrome	3.19e-05	0.000202	CcSEcCtD
Cyclophosphamide—Nausea—Fosphenytoin—epilepsy syndrome	3.19e-05	0.000202	CcSEcCtD
Cyclophosphamide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.18e-05	0.000201	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Topiramate—epilepsy syndrome	3.18e-05	0.000201	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.17e-05	0.000201	CcSEcCtD
Cyclophosphamide—Vomiting—Felbamate—epilepsy syndrome	3.17e-05	0.0002	CcSEcCtD
Cyclophosphamide—Pruritus—Carbamazepine—epilepsy syndrome	3.15e-05	0.000199	CcSEcCtD
Cyclophosphamide—Rash—Felbamate—epilepsy syndrome	3.14e-05	0.000199	CcSEcCtD
Cyclophosphamide—Dermatitis—Felbamate—epilepsy syndrome	3.14e-05	0.000199	CcSEcCtD
Cyclophosphamide—Malaise—Gabapentin—epilepsy syndrome	3.13e-05	0.000198	CcSEcCtD
Cyclophosphamide—Tinnitus—Topiramate—epilepsy syndrome	3.13e-05	0.000198	CcSEcCtD
Cyclophosphamide—Headache—Felbamate—epilepsy syndrome	3.12e-05	0.000197	CcSEcCtD
Cyclophosphamide—Confusional state—Pregabalin—epilepsy syndrome	3.12e-05	0.000197	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.12e-05	0.000197	CcSEcCtD
Cyclophosphamide—Flushing—Topiramate—epilepsy syndrome	3.12e-05	0.000197	CcSEcCtD
Cyclophosphamide—Leukopenia—Gabapentin—epilepsy syndrome	3.11e-05	0.000197	CcSEcCtD
Cyclophosphamide—Dizziness—Clonazepam—epilepsy syndrome	3.11e-05	0.000197	CcSEcCtD
Cyclophosphamide—Nausea—Vigabatrin—epilepsy syndrome	3.1e-05	0.000197	CcSEcCtD
Cyclophosphamide—Vomiting—Zonisamide—epilepsy syndrome	3.1e-05	0.000196	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.09e-05	0.000196	CcSEcCtD
Cyclophosphamide—Oedema—Pregabalin—epilepsy syndrome	3.09e-05	0.000196	CcSEcCtD
Cyclophosphamide—Asthenia—Lamotrigine—epilepsy syndrome	3.09e-05	0.000196	CcSEcCtD
Cyclophosphamide—Dizziness—Phenytoin—epilepsy syndrome	3.09e-05	0.000195	CcSEcCtD
Cyclophosphamide—Rash—Zonisamide—epilepsy syndrome	3.07e-05	0.000195	CcSEcCtD
Cyclophosphamide—Infection—Pregabalin—epilepsy syndrome	3.07e-05	0.000194	CcSEcCtD
Cyclophosphamide—Paraesthesia—Valproic Acid—epilepsy syndrome	3.07e-05	0.000194	CcSEcCtD
Cyclophosphamide—Palpitations—Gabapentin—epilepsy syndrome	3.07e-05	0.000194	CcSEcCtD
Cyclophosphamide—Dermatitis—Zonisamide—epilepsy syndrome	3.07e-05	0.000194	CcSEcCtD
Cyclophosphamide—Dizziness—Oxcarbazepine—epilepsy syndrome	3.07e-05	0.000194	CcSEcCtD
Cyclophosphamide—Nausea—Diazepam—epilepsy syndrome	3.06e-05	0.000193	CcSEcCtD
Cyclophosphamide—Headache—Zonisamide—epilepsy syndrome	3.05e-05	0.000193	CcSEcCtD
Cyclophosphamide—Dyspnoea—Valproic Acid—epilepsy syndrome	3.05e-05	0.000193	CcSEcCtD
Cyclophosphamide—Diarrhoea—Carbamazepine—epilepsy syndrome	3.05e-05	0.000193	CcSEcCtD
Cyclophosphamide—Pruritus—Lamotrigine—epilepsy syndrome	3.05e-05	0.000193	CcSEcCtD
Cyclophosphamide—Shock—Pregabalin—epilepsy syndrome	3.04e-05	0.000193	CcSEcCtD
Cyclophosphamide—Cough—Gabapentin—epilepsy syndrome	3.03e-05	0.000192	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.03e-05	0.000192	CcSEcCtD
Cyclophosphamide—Tachycardia—Pregabalin—epilepsy syndrome	3.02e-05	0.000191	CcSEcCtD
Cyclophosphamide—Chills—Topiramate—epilepsy syndrome	3.01e-05	0.000191	CcSEcCtD
Cyclophosphamide—Convulsion—Gabapentin—epilepsy syndrome	3.01e-05	0.000191	CcSEcCtD
Cyclophosphamide—Hypertension—Gabapentin—epilepsy syndrome	3e-05	0.00019	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.99e-05	0.000189	CcSEcCtD
Cyclophosphamide—Vomiting—Clonazepam—epilepsy syndrome	2.99e-05	0.000189	CcSEcCtD
Cyclophosphamide—Decreased appetite—Valproic Acid—epilepsy syndrome	2.97e-05	0.000188	CcSEcCtD
Cyclophosphamide—Alopecia—Topiramate—epilepsy syndrome	2.97e-05	0.000188	CcSEcCtD
Cyclophosphamide—Vomiting—Phenytoin—epilepsy syndrome	2.97e-05	0.000188	CcSEcCtD
Cyclophosphamide—Rash—Clonazepam—epilepsy syndrome	2.96e-05	0.000188	CcSEcCtD
Cyclophosphamide—Dermatitis—Clonazepam—epilepsy syndrome	2.96e-05	0.000187	CcSEcCtD
Cyclophosphamide—Arthralgia—Gabapentin—epilepsy syndrome	2.96e-05	0.000187	CcSEcCtD
Cyclophosphamide—Myalgia—Gabapentin—epilepsy syndrome	2.96e-05	0.000187	CcSEcCtD
Cyclophosphamide—Chest pain—Gabapentin—epilepsy syndrome	2.96e-05	0.000187	CcSEcCtD
Cyclophosphamide—Nausea—Felbamate—epilepsy syndrome	2.96e-05	0.000187	CcSEcCtD
Cyclophosphamide—Vomiting—Oxcarbazepine—epilepsy syndrome	2.95e-05	0.000187	CcSEcCtD
Cyclophosphamide—Fatigue—Valproic Acid—epilepsy syndrome	2.95e-05	0.000187	CcSEcCtD
Cyclophosphamide—Anorexia—Pregabalin—epilepsy syndrome	2.95e-05	0.000187	CcSEcCtD
Cyclophosphamide—Dizziness—Carbamazepine—epilepsy syndrome	2.95e-05	0.000186	CcSEcCtD
Cyclophosphamide—Diarrhoea—Lamotrigine—epilepsy syndrome	2.95e-05	0.000186	CcSEcCtD
Cyclophosphamide—Headache—Clonazepam—epilepsy syndrome	2.94e-05	0.000186	CcSEcCtD
Cyclophosphamide—Rash—Phenytoin—epilepsy syndrome	2.94e-05	0.000186	CcSEcCtD
Cyclophosphamide—Dermatitis—Phenytoin—epilepsy syndrome	2.94e-05	0.000186	CcSEcCtD
Cyclophosphamide—Rash—Oxcarbazepine—epilepsy syndrome	2.93e-05	0.000185	CcSEcCtD
Cyclophosphamide—Pain—Valproic Acid—epilepsy syndrome	2.93e-05	0.000185	CcSEcCtD
Cyclophosphamide—Constipation—Valproic Acid—epilepsy syndrome	2.93e-05	0.000185	CcSEcCtD
Cyclophosphamide—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.92e-05	0.000185	CcSEcCtD
Cyclophosphamide—Headache—Phenytoin—epilepsy syndrome	2.92e-05	0.000185	CcSEcCtD
Cyclophosphamide—Erythema—Topiramate—epilepsy syndrome	2.92e-05	0.000185	CcSEcCtD
Cyclophosphamide—Discomfort—Gabapentin—epilepsy syndrome	2.92e-05	0.000185	CcSEcCtD
Cyclophosphamide—Headache—Oxcarbazepine—epilepsy syndrome	2.91e-05	0.000184	CcSEcCtD
Cyclophosphamide—Nausea—Zonisamide—epilepsy syndrome	2.9e-05	0.000183	CcSEcCtD
Cyclophosphamide—Hypotension—Pregabalin—epilepsy syndrome	2.89e-05	0.000183	CcSEcCtD
Cyclophosphamide—Dysgeusia—Topiramate—epilepsy syndrome	2.86e-05	0.000181	CcSEcCtD
Cyclophosphamide—Confusional state—Gabapentin—epilepsy syndrome	2.86e-05	0.000181	CcSEcCtD
Cyclophosphamide—Dizziness—Lamotrigine—epilepsy syndrome	2.85e-05	0.00018	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.84e-05	0.00018	CcSEcCtD
Cyclophosphamide—Oedema—Gabapentin—epilepsy syndrome	2.84e-05	0.00018	CcSEcCtD
Cyclophosphamide—Vomiting—Carbamazepine—epilepsy syndrome	2.83e-05	0.000179	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.82e-05	0.000178	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.82e-05	0.000178	CcSEcCtD
Cyclophosphamide—Infection—Gabapentin—epilepsy syndrome	2.82e-05	0.000178	CcSEcCtD
Cyclophosphamide—Muscle spasms—Topiramate—epilepsy syndrome	2.81e-05	0.000178	CcSEcCtD
Cyclophosphamide—Rash—Carbamazepine—epilepsy syndrome	2.81e-05	0.000178	CcSEcCtD
Cyclophosphamide—Dermatitis—Carbamazepine—epilepsy syndrome	2.81e-05	0.000178	CcSEcCtD
Cyclophosphamide—Nausea—Clonazepam—epilepsy syndrome	2.79e-05	0.000177	CcSEcCtD
Cyclophosphamide—Headache—Carbamazepine—epilepsy syndrome	2.79e-05	0.000177	CcSEcCtD
Cyclophosphamide—Shock—Gabapentin—epilepsy syndrome	2.79e-05	0.000177	CcSEcCtD
Cyclophosphamide—Paraesthesia—Pregabalin—epilepsy syndrome	2.78e-05	0.000176	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.78e-05	0.000176	CcSEcCtD
Cyclophosphamide—Nausea—Phenytoin—epilepsy syndrome	2.77e-05	0.000175	CcSEcCtD
Cyclophosphamide—Tachycardia—Gabapentin—epilepsy syndrome	2.77e-05	0.000175	CcSEcCtD
Cyclophosphamide—Dyspnoea—Pregabalin—epilepsy syndrome	2.76e-05	0.000175	CcSEcCtD
Cyclophosphamide—Nausea—Oxcarbazepine—epilepsy syndrome	2.76e-05	0.000175	CcSEcCtD
Cyclophosphamide—Vision blurred—Topiramate—epilepsy syndrome	2.76e-05	0.000174	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.74e-05	0.000174	CcSEcCtD
Cyclophosphamide—Tremor—Topiramate—epilepsy syndrome	2.74e-05	0.000173	CcSEcCtD
Cyclophosphamide—Vomiting—Lamotrigine—epilepsy syndrome	2.74e-05	0.000173	CcSEcCtD
Cyclophosphamide—Urticaria—Valproic Acid—epilepsy syndrome	2.72e-05	0.000172	CcSEcCtD
Cyclophosphamide—Rash—Lamotrigine—epilepsy syndrome	2.71e-05	0.000172	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Topiramate—epilepsy syndrome	2.71e-05	0.000172	CcSEcCtD
Cyclophosphamide—Dermatitis—Lamotrigine—epilepsy syndrome	2.71e-05	0.000172	CcSEcCtD
Cyclophosphamide—Body temperature increased—Valproic Acid—epilepsy syndrome	2.7e-05	0.000171	CcSEcCtD
Cyclophosphamide—Anorexia—Gabapentin—epilepsy syndrome	2.7e-05	0.000171	CcSEcCtD
Cyclophosphamide—Anaemia—Topiramate—epilepsy syndrome	2.7e-05	0.000171	CcSEcCtD
Cyclophosphamide—Headache—Lamotrigine—epilepsy syndrome	2.7e-05	0.000171	CcSEcCtD
Cyclophosphamide—Decreased appetite—Pregabalin—epilepsy syndrome	2.69e-05	0.00017	CcSEcCtD
Cyclophosphamide—Agitation—Topiramate—epilepsy syndrome	2.69e-05	0.00017	CcSEcCtD
Cyclophosphamide—Fatigue—Pregabalin—epilepsy syndrome	2.67e-05	0.000169	CcSEcCtD
Cyclophosphamide—Hypotension—Gabapentin—epilepsy syndrome	2.65e-05	0.000168	CcSEcCtD
Cyclophosphamide—Nausea—Carbamazepine—epilepsy syndrome	2.65e-05	0.000167	CcSEcCtD
Cyclophosphamide—Pain—Pregabalin—epilepsy syndrome	2.64e-05	0.000167	CcSEcCtD
Cyclophosphamide—Constipation—Pregabalin—epilepsy syndrome	2.64e-05	0.000167	CcSEcCtD
Cyclophosphamide—Malaise—Topiramate—epilepsy syndrome	2.64e-05	0.000167	CcSEcCtD
Cyclophosphamide—Leukopenia—Topiramate—epilepsy syndrome	2.62e-05	0.000166	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.58e-05	0.000164	CcSEcCtD
Cyclophosphamide—Palpitations—Topiramate—epilepsy syndrome	2.58e-05	0.000164	CcSEcCtD
Cyclophosphamide—Nausea—Lamotrigine—epilepsy syndrome	2.56e-05	0.000162	CcSEcCtD
Cyclophosphamide—Cough—Topiramate—epilepsy syndrome	2.55e-05	0.000161	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Pregabalin—epilepsy syndrome	2.55e-05	0.000161	CcSEcCtD
Cyclophosphamide—Paraesthesia—Gabapentin—epilepsy syndrome	2.55e-05	0.000161	CcSEcCtD
Cyclophosphamide—Convulsion—Topiramate—epilepsy syndrome	2.53e-05	0.00016	CcSEcCtD
Cyclophosphamide—Dyspnoea—Gabapentin—epilepsy syndrome	2.53e-05	0.00016	CcSEcCtD
Cyclophosphamide—Hypertension—Topiramate—epilepsy syndrome	2.52e-05	0.00016	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.52e-05	0.00016	CcSEcCtD
Cyclophosphamide—Chest pain—Topiramate—epilepsy syndrome	2.49e-05	0.000158	CcSEcCtD
Cyclophosphamide—Arthralgia—Topiramate—epilepsy syndrome	2.49e-05	0.000158	CcSEcCtD
Cyclophosphamide—Myalgia—Topiramate—epilepsy syndrome	2.49e-05	0.000158	CcSEcCtD
Cyclophosphamide—Decreased appetite—Gabapentin—epilepsy syndrome	2.47e-05	0.000156	CcSEcCtD
Cyclophosphamide—Discomfort—Topiramate—epilepsy syndrome	2.46e-05	0.000156	CcSEcCtD
Cyclophosphamide—Urticaria—Pregabalin—epilepsy syndrome	2.46e-05	0.000156	CcSEcCtD
Cyclophosphamide—Asthenia—Valproic Acid—epilepsy syndrome	2.45e-05	0.000155	CcSEcCtD
Cyclophosphamide—Fatigue—Gabapentin—epilepsy syndrome	2.45e-05	0.000155	CcSEcCtD
Cyclophosphamide—Body temperature increased—Pregabalin—epilepsy syndrome	2.45e-05	0.000155	CcSEcCtD
Cyclophosphamide—Constipation—Gabapentin—epilepsy syndrome	2.43e-05	0.000154	CcSEcCtD
Cyclophosphamide—Pain—Gabapentin—epilepsy syndrome	2.43e-05	0.000154	CcSEcCtD
Cyclophosphamide—Pruritus—Valproic Acid—epilepsy syndrome	2.42e-05	0.000153	CcSEcCtD
Cyclophosphamide—Confusional state—Topiramate—epilepsy syndrome	2.41e-05	0.000152	CcSEcCtD
Cyclophosphamide—Oedema—Topiramate—epilepsy syndrome	2.39e-05	0.000151	CcSEcCtD
Cyclophosphamide—Infection—Topiramate—epilepsy syndrome	2.37e-05	0.00015	CcSEcCtD
Cyclophosphamide—Shock—Topiramate—epilepsy syndrome	2.35e-05	0.000149	CcSEcCtD
Cyclophosphamide—Diarrhoea—Valproic Acid—epilepsy syndrome	2.34e-05	0.000148	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Gabapentin—epilepsy syndrome	2.34e-05	0.000148	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Topiramate—epilepsy syndrome	2.34e-05	0.000148	CcSEcCtD
Cyclophosphamide—Tachycardia—Topiramate—epilepsy syndrome	2.33e-05	0.000147	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Topiramate—epilepsy syndrome	2.31e-05	0.000146	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Pregabalin—epilepsy syndrome	2.28e-05	0.000144	CcSEcCtD
Cyclophosphamide—Anorexia—Topiramate—epilepsy syndrome	2.27e-05	0.000144	CcSEcCtD
Cyclophosphamide—Dizziness—Valproic Acid—epilepsy syndrome	2.26e-05	0.000143	CcSEcCtD
Cyclophosphamide—Urticaria—Gabapentin—epilepsy syndrome	2.25e-05	0.000143	CcSEcCtD
Cyclophosphamide—Body temperature increased—Gabapentin—epilepsy syndrome	2.24e-05	0.000142	CcSEcCtD
Cyclophosphamide—Hypotension—Topiramate—epilepsy syndrome	2.23e-05	0.000141	CcSEcCtD
Cyclophosphamide—Asthenia—Pregabalin—epilepsy syndrome	2.22e-05	0.00014	CcSEcCtD
Cyclophosphamide—Pruritus—Pregabalin—epilepsy syndrome	2.19e-05	0.000139	CcSEcCtD
Cyclophosphamide—Vomiting—Valproic Acid—epilepsy syndrome	2.18e-05	0.000138	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.17e-05	0.000138	CcSEcCtD
Cyclophosphamide—Rash—Valproic Acid—epilepsy syndrome	2.16e-05	0.000137	CcSEcCtD
Cyclophosphamide—Dermatitis—Valproic Acid—epilepsy syndrome	2.16e-05	0.000136	CcSEcCtD
Cyclophosphamide—Headache—Valproic Acid—epilepsy syndrome	2.14e-05	0.000136	CcSEcCtD
Cyclophosphamide—Paraesthesia—Topiramate—epilepsy syndrome	2.14e-05	0.000136	CcSEcCtD
Cyclophosphamide—Dyspnoea—Topiramate—epilepsy syndrome	2.13e-05	0.000135	CcSEcCtD
Cyclophosphamide—Diarrhoea—Pregabalin—epilepsy syndrome	2.12e-05	0.000134	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Gabapentin—epilepsy syndrome	2.09e-05	0.000132	CcSEcCtD
Cyclophosphamide—Decreased appetite—Topiramate—epilepsy syndrome	2.07e-05	0.000131	CcSEcCtD
Cyclophosphamide—Fatigue—Topiramate—epilepsy syndrome	2.06e-05	0.00013	CcSEcCtD
Cyclophosphamide—Dizziness—Pregabalin—epilepsy syndrome	2.05e-05	0.000129	CcSEcCtD
Cyclophosphamide—Pain—Topiramate—epilepsy syndrome	2.04e-05	0.000129	CcSEcCtD
Cyclophosphamide—Constipation—Topiramate—epilepsy syndrome	2.04e-05	0.000129	CcSEcCtD
Cyclophosphamide—Asthenia—Gabapentin—epilepsy syndrome	2.03e-05	0.000129	CcSEcCtD
Cyclophosphamide—Nausea—Valproic Acid—epilepsy syndrome	2.03e-05	0.000129	CcSEcCtD
Cyclophosphamide—Pruritus—Gabapentin—epilepsy syndrome	2.01e-05	0.000127	CcSEcCtD
Cyclophosphamide—Vomiting—Pregabalin—epilepsy syndrome	1.97e-05	0.000124	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Topiramate—epilepsy syndrome	1.97e-05	0.000124	CcSEcCtD
Cyclophosphamide—Rash—Pregabalin—epilepsy syndrome	1.95e-05	0.000123	CcSEcCtD
Cyclophosphamide—Dermatitis—Pregabalin—epilepsy syndrome	1.95e-05	0.000123	CcSEcCtD
Cyclophosphamide—Diarrhoea—Gabapentin—epilepsy syndrome	1.94e-05	0.000123	CcSEcCtD
Cyclophosphamide—Headache—Pregabalin—epilepsy syndrome	1.94e-05	0.000123	CcSEcCtD
Cyclophosphamide—Urticaria—Topiramate—epilepsy syndrome	1.9e-05	0.00012	CcSEcCtD
Cyclophosphamide—Body temperature increased—Topiramate—epilepsy syndrome	1.89e-05	0.000119	CcSEcCtD
Cyclophosphamide—Dizziness—Gabapentin—epilepsy syndrome	1.88e-05	0.000119	CcSEcCtD
Cyclophosphamide—Nausea—Pregabalin—epilepsy syndrome	1.84e-05	0.000116	CcSEcCtD
Cyclophosphamide—Vomiting—Gabapentin—epilepsy syndrome	1.8e-05	0.000114	CcSEcCtD
Cyclophosphamide—Rash—Gabapentin—epilepsy syndrome	1.79e-05	0.000113	CcSEcCtD
Cyclophosphamide—Dermatitis—Gabapentin—epilepsy syndrome	1.79e-05	0.000113	CcSEcCtD
Cyclophosphamide—Headache—Gabapentin—epilepsy syndrome	1.78e-05	0.000112	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Topiramate—epilepsy syndrome	1.76e-05	0.000111	CcSEcCtD
Cyclophosphamide—Asthenia—Topiramate—epilepsy syndrome	1.71e-05	0.000108	CcSEcCtD
Cyclophosphamide—Pruritus—Topiramate—epilepsy syndrome	1.69e-05	0.000107	CcSEcCtD
Cyclophosphamide—Nausea—Gabapentin—epilepsy syndrome	1.68e-05	0.000107	CcSEcCtD
Cyclophosphamide—Diarrhoea—Topiramate—epilepsy syndrome	1.63e-05	0.000103	CcSEcCtD
Cyclophosphamide—Dizziness—Topiramate—epilepsy syndrome	1.58e-05	9.99e-05	CcSEcCtD
Cyclophosphamide—Vomiting—Topiramate—epilepsy syndrome	1.52e-05	9.6e-05	CcSEcCtD
Cyclophosphamide—Rash—Topiramate—epilepsy syndrome	1.5e-05	9.52e-05	CcSEcCtD
Cyclophosphamide—Dermatitis—Topiramate—epilepsy syndrome	1.5e-05	9.51e-05	CcSEcCtD
Cyclophosphamide—Headache—Topiramate—epilepsy syndrome	1.49e-05	9.46e-05	CcSEcCtD
Cyclophosphamide—Nausea—Topiramate—epilepsy syndrome	1.42e-05	8.97e-05	CcSEcCtD
Cyclophosphamide—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	5.54e-06	0.000152	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	5.53e-06	0.000152	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—TH—epilepsy syndrome	5.52e-06	0.000152	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GLUL—epilepsy syndrome	5.49e-06	0.000151	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	5.44e-06	0.00015	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	5.44e-06	0.00015	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	5.44e-06	0.00015	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—AGT—epilepsy syndrome	5.42e-06	0.000149	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ADRA2A—epilepsy syndrome	5.4e-06	0.000149	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	5.4e-06	0.000149	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	5.39e-06	0.000148	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—BCHE—epilepsy syndrome	5.38e-06	0.000148	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—AQP1—epilepsy syndrome	5.37e-06	0.000148	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.36e-06	0.000148	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	5.33e-06	0.000147	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	5.33e-06	0.000147	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	5.33e-06	0.000147	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	5.33e-06	0.000147	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	5.33e-06	0.000147	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.32e-06	0.000146	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—APOE—epilepsy syndrome	5.31e-06	0.000146	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—AQP1—epilepsy syndrome	5.24e-06	0.000144	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ABCG2—epilepsy syndrome	5.24e-06	0.000144	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.16e-06	0.000142	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—SLC2A1—epilepsy syndrome	5.13e-06	0.000141	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	5.12e-06	0.000141	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP2C19—epilepsy syndrome	5.11e-06	0.000141	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	5.09e-06	0.00014	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PLCB1—epilepsy syndrome	5.08e-06	0.00014	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP11A1—epilepsy syndrome	5.07e-06	0.00014	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.07e-06	0.000139	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—TH—epilepsy syndrome	5.06e-06	0.000139	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	5.04e-06	0.000139	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	4.99e-06	0.000137	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.96e-06	0.000137	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	4.96e-06	0.000136	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—AQP1—epilepsy syndrome	4.94e-06	0.000136	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—AQP1—epilepsy syndrome	4.9e-06	0.000135	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	4.87e-06	0.000134	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	4.87e-06	0.000134	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	4.87e-06	0.000134	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	4.86e-06	0.000134	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	4.86e-06	0.000134	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	4.79e-06	0.000132	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CHRM3—epilepsy syndrome	4.74e-06	0.00013	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	4.74e-06	0.00013	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.7e-06	0.000129	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	4.69e-06	0.000129	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	4.61e-06	0.000127	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	4.58e-06	0.000126	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—POMC—epilepsy syndrome	4.56e-06	0.000126	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CAT—epilepsy syndrome	4.54e-06	0.000125	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	4.53e-06	0.000125	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	4.53e-06	0.000125	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.52e-06	0.000124	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	4.48e-06	0.000123	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	4.47e-06	0.000123	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	4.47e-06	0.000123	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	4.44e-06	0.000122	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.43e-06	0.000122	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	4.43e-06	0.000122	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	4.43e-06	0.000122	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	4.42e-06	0.000122	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	4.36e-06	0.00012	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—BCHE—epilepsy syndrome	4.34e-06	0.000119	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	4.32e-06	0.000119	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	4.3e-06	0.000118	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.26e-06	0.000117	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.26e-06	0.000117	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	4.26e-06	0.000117	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—BCHE—epilepsy syndrome	4.24e-06	0.000117	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	4.22e-06	0.000116	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CAT—epilepsy syndrome	4.17e-06	0.000115	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—ALB—epilepsy syndrome	4.16e-06	0.000114	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.15e-06	0.000114	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	4.14e-06	0.000114	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.12e-06	0.000113	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—GPX1—epilepsy syndrome	4.11e-06	0.000113	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	4.1e-06	0.000113	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—TH—epilepsy syndrome	4.08e-06	0.000112	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	4.05e-06	0.000112	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	4.05e-06	0.000111	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.04e-06	0.000111	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.04e-06	0.000111	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.04e-06	0.000111	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	4e-06	0.00011	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—TH—epilepsy syndrome	3.99e-06	0.00011	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	3.96e-06	0.000109	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.89e-06	0.000107	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	3.88e-06	0.000107	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ABCG2—epilepsy syndrome	3.86e-06	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.85e-06	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.85e-06	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	3.83e-06	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.81e-06	0.000105	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.77e-06	0.000104	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GPX1—epilepsy syndrome	3.77e-06	0.000104	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	3.77e-06	0.000104	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	3.74e-06	0.000103	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.69e-06	0.000102	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	3.69e-06	0.000102	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—BCHE—epilepsy syndrome	3.68e-06	0.000101	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	3.64e-06	0.0001	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PTGS2—epilepsy syndrome	3.64e-06	0.0001	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.62e-06	9.97e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	3.61e-06	9.93e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—AGT—epilepsy syndrome	3.6e-06	9.92e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	3.57e-06	9.82e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.56e-06	9.79e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.55e-06	9.77e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—APOE—epilepsy syndrome	3.53e-06	9.72e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.53e-06	9.71e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	3.52e-06	9.68e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	3.51e-06	9.65e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	3.5e-06	9.62e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.47e-06	9.55e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.47e-06	9.55e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	3.47e-06	9.54e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	3.46e-06	9.52e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—TH—epilepsy syndrome	3.46e-06	9.51e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	3.41e-06	9.37e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.4e-06	9.36e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	3.38e-06	9.3e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CAT—epilepsy syndrome	3.36e-06	9.25e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	3.33e-06	9.16e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.33e-06	9.15e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—AGT—epilepsy syndrome	3.3e-06	9.09e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	3.29e-06	9.07e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CAT—epilepsy syndrome	3.29e-06	9.04e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—BCHE—epilepsy syndrome	3.28e-06	9.03e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	3.27e-06	9e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—APOE—epilepsy syndrome	3.24e-06	8.91e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.23e-06	8.89e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.22e-06	8.86e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	3.22e-06	8.85e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—BCHE—epilepsy syndrome	3.2e-06	8.81e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	3.2e-06	8.8e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.16e-06	8.71e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.16e-06	8.68e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.13e-06	8.61e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.1e-06	8.52e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—TH—epilepsy syndrome	3.08e-06	8.49e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	3.05e-06	8.41e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GPX1—epilepsy syndrome	3.04e-06	8.37e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.04e-06	8.36e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—POMC—epilepsy syndrome	3.03e-06	8.35e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.03e-06	8.34e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PLCB1—epilepsy syndrome	3.02e-06	8.31e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.02e-06	8.3e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—TH—epilepsy syndrome	3.01e-06	8.28e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3e-06	8.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.99e-06	8.23e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GPX1—epilepsy syndrome	2.97e-06	8.18e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.92e-06	8.04e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.92e-06	8.04e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	2.88e-06	7.94e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.88e-06	7.92e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.85e-06	7.85e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.85e-06	7.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CAT—epilepsy syndrome	2.85e-06	7.83e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—TH—epilepsy syndrome	2.84e-06	7.81e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.82e-06	7.77e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—TH—epilepsy syndrome	2.81e-06	7.74e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—POMC—epilepsy syndrome	2.78e-06	7.65e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.77e-06	7.62e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	2.77e-06	7.62e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ALB—epilepsy syndrome	2.77e-06	7.61e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—AGT—epilepsy syndrome	2.67e-06	7.34e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—APOE—epilepsy syndrome	2.61e-06	7.19e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—AGT—epilepsy syndrome	2.61e-06	7.17e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.57e-06	7.08e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GPX1—epilepsy syndrome	2.57e-06	7.08e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—APOE—epilepsy syndrome	2.55e-06	7.02e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.54e-06	6.99e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ALB—epilepsy syndrome	2.54e-06	6.98e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.51e-06	6.91e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CAT—epilepsy syndrome	2.48e-06	6.82e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.47e-06	6.8e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	2.42e-06	6.66e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.38e-06	6.55e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.37e-06	6.52e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.35e-06	6.46e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.34e-06	6.43e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.32e-06	6.38e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.32e-06	6.37e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.31e-06	6.35e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.3e-06	6.32e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.27e-06	6.25e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—AGT—epilepsy syndrome	2.26e-06	6.21e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.25e-06	6.2e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—POMC—epilepsy syndrome	2.24e-06	6.17e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.24e-06	6.17e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	2.22e-06	6.1e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—APOE—epilepsy syndrome	2.21e-06	6.08e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—POMC—epilepsy syndrome	2.19e-06	6.03e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.11e-06	5.81e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.09e-06	5.76e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.08e-06	5.73e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ALB—epilepsy syndrome	2.05e-06	5.63e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.01e-06	5.54e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ALB—epilepsy syndrome	2e-06	5.5e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.98e-06	5.45e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.97e-06	5.43e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.97e-06	5.43e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—AGT—epilepsy syndrome	1.97e-06	5.41e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—APOE—epilepsy syndrome	1.93e-06	5.3e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.9e-06	5.23e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.88e-06	5.18e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.86e-06	5.12e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—TH—epilepsy syndrome	1.85e-06	5.1e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.85e-06	5.1e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.84e-06	5.05e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—AKT1—epilepsy syndrome	1.83e-06	5.03e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.82e-06	5e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.8e-06	4.95e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	1.79e-06	4.92e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.75e-06	4.81e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.73e-06	4.77e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.7e-06	4.67e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—POMC—epilepsy syndrome	1.65e-06	4.55e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.56e-06	4.29e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.55e-06	4.26e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.55e-06	4.25e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.55e-06	4.25e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.53e-06	4.2e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.51e-06	4.17e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ALB—epilepsy syndrome	1.51e-06	4.15e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.49e-06	4.09e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.42e-06	3.91e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.41e-06	3.88e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.38e-06	3.8e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.35e-06	3.72e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.32e-06	3.63e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.24e-06	3.42e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.23e-06	3.39e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—AKT1—epilepsy syndrome	1.22e-06	3.35e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.21e-06	3.33e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.19e-06	3.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—AKT1—epilepsy syndrome	1.11e-06	3.07e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.02e-06	2.81e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALB—epilepsy syndrome	9.29e-07	2.56e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—AKT1—epilepsy syndrome	8.99e-07	2.48e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—AKT1—epilepsy syndrome	8.79e-07	2.42e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	8.13e-07	2.24e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—AKT1—epilepsy syndrome	7.61e-07	2.1e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—AKT1—epilepsy syndrome	6.8e-07	1.87e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—AKT1—epilepsy syndrome	6.63e-07	1.83e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—AKT1—epilepsy syndrome	6.25e-07	1.72e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—AKT1—epilepsy syndrome	6.2e-07	1.71e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.09e-07	1.12e-05	CbGpPWpGaD
